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Despite all the human efforts and monetary investment 
over the last few decades, cancer is still a devastating 
threat to our life expectancy and quality of life in many 
parts of the world. The etiology of cancer varies. The 
genetic and epigenetic causes of cancer are heterogene-
ous and multifaceted. Early detection is still a difficult 
issue in many types of malignancies, resulting in unsat-
isfying cure rates. Cancer not only is a disease of malig-
nant cells but also involves the host physiology, especially 
the natural defensive immune systems. The task of over-
coming cancer is so vast and overwhelming that it will 
no doubt require scientists worldwide to join efforts and 
resources to succeed.
The year of 2016 is the 150th year Anniversary of Dr. 
Sun Yat-sen’s birth. Dr. Sun was a doctor who devoted his 
life to treating patients and to revolutionizing the history 
of mankind by putting China on a path for moderniza-
tion. We seek to honor Dr. Sun Yat-sen’s legacy by solic-
iting 150 most important questions in the war against 
cancer from cancer researchers and clinicians worldwide. 
We hope that presenting the most important questions 
in cancer research and clinical oncology would be ben-
eficial to stimulating all cancer fighters, especially young 
generation researchers to focus on the key issues that will 
generate the most significant impact on cancer cures.
A significant number of questions have been submitted 
by clinicians and researchers covering the fields of can-
cer etiology, cancer immunology, metabolism, biology, 
prevention, early detection, treatment modality, drug 
development, novel experimental technology, and can-
cer-induced erythrogenesis.
Starting in the December issue of 2016, the Chinese 
Journal of Cancer will publish a series of peer-reviewed 
top-ranked questions from several categories. We hope 
these questions will further trigger a brainstorm among 
cancer researchers and encourage continued submis-
sion of key questions and research articles in the coming 
months to the Chinese Journal of Cancer as a special trib-
ute to Dr. Sun Yat-sen.
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